Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Clinical fellowship augmented by regulatory review experience: a perspective on the Children's National Hospital/FDA fellowship tracks.
Journal: Proceedings (Baylor University. Medical Center)
Published: June 24, 2024
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program.
Journal: Journal of clinical pharmacology
Published: July 06, 2022
FDA Approval of Remdesivir - A Step in the Right Direction.
Journal: The New England journal of medicine
Published: December 02, 2020
The varying specificity of urine cultures in different populations.
Journal: Infection control and hospital epidemiology
Published: February 11, 2020
Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials.
Journal: Journal of virus eradication
Published: November 09, 2019
Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.
Journal: The Lancet. Infectious diseases
Published: August 31, 2018
HCV genotype 4, 5 and 6: Distribution of viral subtypes and sustained virologic response rates in clinical trials of approved direct-acting antiviral regimens.
Journal: Journal of viral hepatitis
Published: November 14, 2017
Benefit-risk assessment for sofosbuvir/velpatasvir/voxilaprevir based on patient population and hepatitis C virus genotype: U. S. Food and Drug Administration's evaluation.
Journal: Hepatology (Baltimore, Md.)
Published: July 28, 2017
How Often Are Drugs Made Available Under the Food and Drug Administration's Expanded Access Process Approved?
Journal: Journal of clinical pharmacology
Published: January 13, 2017
Expanded access to investigational drugs.
Journal: The New England journal of medicine
Published: April 09, 2015
Last Updated: 09/26/2026